EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Improvement in Glycolipid Metabolism Parameters After Supplementing Fish Oil-Derived Omega-3 Fatty Acids Is Associated with Gut Microbiota and Lipid Metabolites in Type 2 Diabetes Mellitus

Jiayue Xia, Shiyu Yin, Junhui Yu iD, Jiongnan Wang, Xingyi Jin, Yuanyuan Wang, Hechun Liu, Guiju Sun iD

Nutrients · 2024

DOI: 10.3390/nu16213755 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Jiayue Xia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, Chi…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Diabetes Mellitus, Type 2, Fatty Acids, Omega-3, Fish Oils. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: THE NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA, NATURAL SCIENCE FOUNDATION OF JIANGSU PROVINCE, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: This study aimed to investigate the effects of fish oil-derived omega-3 polyunsaturated fatty acids (omega-3 PUFAs) on gut microbiota and serum lipid metabolites in T2DM.

Methods

In a three-month, randomized, double-blind, placebo-controlled study, 110 T2DM patients received either fish oil (n = 55) or corn oil (n = 55) capsules daily. Serum lipids, glycemic parameters, gut microbiota diversity, and lipidomics were assessed.

Results

This study found that fish oil-derived omega-3 PUFAs intervention did not significantly lower the fasting plasma glucose levels when compared with the baseline level (p > 0.05). However, serum fasting blood glucose (p = 0.039), glycosylated hemoglobin levels (p = 0.048), HOMA-IR (p = 0.022), total cholesterol (p < 0.001), triglyceride (p = 0.034), LDL cholesterol (p = 0.048), and non-HDL levels (p = 0.046) were significantly lower in the fish oil group compared with the corn oil group after three months of intervention. Also, it altered glycerophospholipid metabolism and gut microbiota. After three months, the fish oil group showed a significantly lower abundance of Desulfobacterota compared with the corn oil control group (p = 0.003), with reduced levels of Colidextribacter (p = 0.002), Ralstonia (p = 0.021), and Klebsiella (p = 0.013). Conversely, the abundance of Limosilactobacillus (p = 0.017), Lactobacillus (p = 0.011), and Haemophilus (p = 0.018) increased significantly. In addition, relevant glycolipid metabolism indicators showed significant correlations with the altered profiles of serum lipid metabolites, intestinal bacteria, and fungi.

Conclusions

This study highlights the impact of fish oil-derived omega-3 PUFAs on intestinal microbiota structure and function in patients with type 2 diabetes. The observed decrease in pathogenic bacterial species and the enhancement of beneficial species may have significant implications for gut health and systemic inflammation, both of which are pivotal in managing diabetes. Further research is warranted to comprehensively elucidate the long-term benefits and underlying mechanisms of these microbiota alterations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeDiabetes Mellitus, Type 2Fatty Acids, Omega-3Fish OilsLipid MetabolismDietary SupplementsGlycolipidsHumansMaleFemaleMiddle AgedDouble-Blind MethodBlood GlucoseAdultAgedGlycated Hemoglobin

Stichwörter der Autor:innen

blood glucoseblood lipidsglycerophospholipidgut microbiotaomega-3 fatty acidstype 2 diabetes mellitus

Substanzen

Fatty Acids, Omega-3Fish OilsGlycolipidsBlood GlucoseGlycated Hemoglobin

Autor:innen und Institutionen

  • Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China.
  • Department of Nutrition and Food Hygiene, School of Public Health, Southeast University, Nanjing 210009, China.
  • Department of Endocrinology and Metabolism, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China.

ORCID-Profile: Junhui Yu, Guiju Sun

Förderung

  • THE NATIONAL NATURAL SCIENCE FOUNDATION OF CHINA
  • NATURAL SCIENCE FOUNDATION OF JIANGSU PROVINCE
  • National Natural Science Foundation of China

Zitieren

APA

Xia, J., Yin, S., Yu, J., Wang, J., Jin, X., Wang, Y., Liu, H., & Sun, G. (2024). Improvement in Glycolipid Metabolism Parameters After Supplementing Fish Oil-Derived Omega-3 Fatty Acids Is Associated with Gut Microbiota and Lipid Metabolites in Type 2 Diabetes Mellitus. Nutrients. https://doi.org/10.3390/nu16213755

Vancouver

Xia J, Yin S, Yu J, Wang J, Jin X, Wang Y, et al. Improvement in Glycolipid Metabolism Parameters After Supplementing Fish Oil-Derived Omega-3 Fatty Acids Is Associated with Gut Microbiota and Lipid Metabolites in Type 2 Diabetes Mellitus. Nutrients. 2024. doi:10.3390/nu16213755

BibTeX
@article{Xia2024,
  author = {Xia, Jiayue and Yin, Shiyu and Yu, Junhui and Wang, Jiongnan and Jin, Xingyi and Wang, Yuanyuan and Liu, Hechun and Sun, Guiju},
  title = {Improvement in Glycolipid Metabolism Parameters After Supplementing Fish Oil-Derived Omega-3 Fatty Acids Is Associated with Gut Microbiota and Lipid Metabolites in Type 2 Diabetes Mellitus},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16213755}
}
Kostenlos starten →